Results 211 to 220 of about 29,386 (244)
Circulating cell-derived microparticles in malaria patients
, 2016 Nantakomon, D +6 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Red blood cell-derived microparticles: An overview
Blood Cells, Molecules, and Diseases, 2016The red blood cell (RBC) is historically the original parent cell of microparticles (MPs). In this overview, we describe the discovery and the early history of red cell-derived microparticles (RMPs) and present an overview of the evolution of RMP. We report the formation, characteristics, effects of RMP and factors which may affect RMP evaluation.
exaly +3 more sources
Red cell-derived microparticles (RMP) as haemostatic agent
Thrombosis and Haemostasis, 2013SummaryAmong circulating cell-derived microparticles, those derived from red cells (RMP) have been least well investigated. To exploit potential haemostatic benefit of RMP, we developed a method of producing them in quantity, and here report on their haemostatic properties. High-pressure extrusion of washed RBC was employed to generate RMP.
Lawrence L Horstman +2 more
exaly +3 more sources
Cell-derived microparticles in haemostasis and vascular medicine
Thrombosis and Haemostasis, 2009SummaryConsiderable interest for cell-derived microparticles has emerged, pointing out their essential role in haemostatic response and their potential as disease markers, but also their implication in a wide range of physiological and pathological processes. They derive from different cell types including platelets – the main source of microparticles –
Burnier, Laurent +3 more
openaire +3 more sources
Circulating Cell-Derived Microparticles in Crohn?s Disease
Digestive Diseases and Sciences, 2005Procoagulant membrane microparticles can be released from activated or apoptotic cells in response to various environmental stimuli. The aim of this study was to investigate the presence of microparticles in Crohn's disease and to assess their variations after infliximab therapy.
Patrick, Chamouard +8 more
openaire +2 more sources
Influence of Cell-Derived Microparticles on Thromboelastography.
Blood, 2010Abstract Abstract 3698 Background. Thromboelastography (TEG) is a method of analyzing coagulation commonly used to assess pre- and perioperative bleeding risk. We have been interested in the role of cell-derived microparticles (MP) in coagulation and in this study, examined correlations
Max E Johansen +6 more
openaire +1 more source
Cell‐Derived Microparticles and Exosomes in Neuroinflammatory Disorders
2007All blood cells and the vascular endothelium shed microparticles (MP) from their plasma membranes when suitably stimulated, and assay of MP in patient blood has found increasing application to the monitoring of disease states. In addition, mounting evidence suggests that MP are not mere epiphenomena but play significant roles in the pathophysiology of ...
Lawrence L, Horstman +6 more
openaire +2 more sources
Pyroptotic cell-derived microparticle: An atherogenic factor in infectious diseases
Medical Hypotheses, 2021Chronic infection is considered a risk factor for atherosclerosis. The link between infectious agents and atherosclerosis is manifested by the presence of infection-induced pyroptotic cells in atherosclerotic lesions. Pyroptosis is an inflammatory form of programmed cell death that occurs most frequently upon infection. However, inflammation is not the
Shao-Wei, Sun +5 more
openaire +2 more sources